DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

01 Mar 2021

2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint

Press Release

2cureX announced today that its prospective interventional clinical trial investigating the benefit of IndiTreat®-guided treatment achieved its primary endpoint by improving Progression Free Survival (PFS) after eight weeks of treatment beyond the primary endpoint. Full data has been submitted to the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.
“These results show there’s a significant improvement for patients when treated according to the IndiTreat® test” said Ole Thastrup, 2cureX’s Chief Scientific Officer. “This is an important achievement in this historically hard-to-treat disease. We are deeply appreciative of the cancer patients and clinical investigators who participated in this trial”.
Colorectal cancer is the 2nd most common cancer in women and the 3th most common in men.

Read the full press release here

  • Press Release PDF

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2021 Danskbiotek. All rights reserved.